Iliopoulos D, Atkinson B, Saul S H, Herlyn M, Rodriguez-Martinez H A, West S L, Maislin G, Soloway R D, Strom B L
Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.
Dig Dis Sci. 1993 Jan;38(1):155-60. doi: 10.1007/BF01296789.
Immunoreactivity for a panel of 15 monoclonal antibodies (MAbs), which are known to react with different gastrointestinal tumor antigens, was assessed in formalin-fixed paraffin-embedded sections that were prepared from cholecystectomy specimens obtained from Mexican patients. Each case was classified histologically into one of the following groups: (1) invasive adenocarcinoma (N = 21), (2) high-grade dysplasia (carcinoma in situ) (N = 2), (3) low-grade dysplasia (N = 4), hyperplasia (4) (N = 15), and (5) chronic cholecystitis (N = 10). Significant differences (P < 0.05) were identified among the five histopathologic groups in the proportion of epithelial cells demonstrating immunoreactivity with MAbs to Lewisb; Lewis(a); sialylated Lewis(a); sialylated Lewis(a) and Lewis(a); Y antigen; H antigen; X antigen; X-like antigen; 200-kDa protein of CEA; 180-, 160-, 50-, 40-kDa proteins of CEA; 30- to 37-kDa protein; and an undefined antigen identified by MAb 99-57, with invasive carcinoma more frequently being positive as compared to nonneoplastic (hyperplasia, chronic cholecystitis) epithelium. Significant differences were also observed among the five histopathologic groups (P < or = 0.0005) in the proportion of epithelial cells demonstrating immunoreactivity with MAbs to Y antigen and the 20- to 50-kDa glycoprotein. However, with these two antibodies immunoreactivity was more frequently found in nonneoplastic epithelium rather than in invasive carcinomas. No significant differences in immunoreactivity were detected among the different histologic groups with MAb to blood group B antigen, types 1 and 2. This study demonstrates that cellular antigens are both developed and lost during the process of neoplastic transformation in the gallbladder.(ABSTRACT TRUNCATED AT 250 WORDS)
在取自墨西哥患者胆囊切除术标本并经福尔马林固定、石蜡包埋的切片中,评估了一组已知可与不同胃肠道肿瘤抗原发生反应的15种单克隆抗体(MAb)的免疫反应性。每个病例经组织学分类为以下组之一:(1)浸润性腺癌(N = 21),(2)高级别发育异常(原位癌)(N = 2),(3)低级别发育异常(N = 4),(4)增生(N = 15),以及(5)慢性胆囊炎(N = 10)。在五个组织病理学组中,显示与针对Lewisb、Lewis(a)、唾液酸化Lewis(a)、唾液酸化Lewis(a)和Lewis(a)、Y抗原、H抗原、X抗原、X样抗原、癌胚抗原(CEA)的200-kDa蛋白、CEA的180-、160-、50-、40-kDa蛋白、30至37-kDa蛋白以及由MAb 99-57鉴定的未定义抗原的MAb发生免疫反应的上皮细胞比例存在显著差异(P < 0.05),与非肿瘤性(增生、慢性胆囊炎)上皮相比,浸润性癌更常呈阳性。在五个组织病理学组中,显示与针对Y抗原和20至50-kDa糖蛋白的MAb发生免疫反应的上皮细胞比例也观察到显著差异(P ≤ 0.0005)。然而,使用这两种抗体时,免疫反应性更常见于非肿瘤性上皮而非浸润性癌。在不同组织学组中,针对血型B抗原1型和2型的MAb未检测到免疫反应性的显著差异。本研究表明,胆囊肿瘤转化过程中细胞抗原既会产生也会丢失。(摘要截断于250字)